Results 111 to 120 of about 424,058 (165)

Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated kidney transplant population: 18-month follow-up. [PDF]

IJID Reg
Karunathilake KRP, Kumara RA, Karunathilaka A, Wazil AWM, Nanayakkara N, Bandara CK, Abeysekera RA, Noordeen F, Gawarammana IB, Ratnatunga CN.   +9 more
europepmc   +1 more source

mRNA-1273/ravulizumab [PDF]

Reactions Weekly, 2021
openaire   +1 more source

Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination \u2014 PCORnet, United States, January 2021\u2013January 2022

What is already known about this topic? Studies have found an increased risk for cardiac Complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination, but few have compared these risks.What is added by this report?

core  

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2. [PDF]

Vaccines (Basel)
Tangsathapornpong A, Nanthapisal S, Fukpho W, Bunjoungmanee P, Neamkul Y, Pontan K, Boonyarangkul A, Wanpen S, Thongphubeth K, Tharabenjasin P, Jaru-Ampornpan P.   +10 more
europepmc   +1 more source

Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines. [PDF]

Cell Rep
Bangaru S, Jackson AM, Copps J, Fernández-Quintero ML, Torres JL, Richey ST, Nogal B, Sewall LM, Torrents de la Peña A, Rehman A, Guebre-Xabier M, Girard B, Das R, Corbett-Helaire KS, Seder RA, Graham BS, Edwards DK, Patel N, Smith G, Ward AB.   +19 more
europepmc   +1 more source

The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination. [PDF]

Sci Rep
Tarriño M, Gutiérrez-Bautista JF, Durán MJO, Garcia-Diaz A, Cabrera-Serrano AJ, Sainz J, Cobo F, Rodriguez T, Reguera JA, Bernal M, López-Nevot MÁ, Sampedro A.   +11 more
europepmc   +1 more source

Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers. [PDF]

Vaccines (Basel)
Lee H, Ko GY, Lee J, Bae H, Ryu JH, Jung J, Kang H, Lee R, Lee DG, Oh EJ.   +9 more
europepmc   +1 more source

Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age. [PDF]

J Infect Dis
Rostad CA, Campbell JD, Paulsen GC, Ghamloush SS, Xu W, Zheng L, McElrath MJ, De Rosa SC, Girard B, Das R, Anderson EJ, Creech CB.   +11 more
europepmc   +1 more source

Immunostimulatory/Immunodynamic model of mRNA-1273 to guide pediatric vaccine dose selection. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ivaturi V, Attarwala H, Deng W, Ding B, Schnyder Ghamloush S, Girard B, Iqbal J, Minnikanti S, Zhou H, Miller J, Das R.   +10 more
europepmc   +1 more source

Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Related Hospitalizations and Medically Attended COVID-19 Among Adults Aged ≥ 18 years in the United States: An Observational Matched Cohort Study. [PDF]

Infect Dis Ther
Vicic N, Bogdanov A, Zheng Z, Ryan T, Zeng N, Joshi K, Lu T, Bonafede M, Araujo AB, Wilson A.   +9 more
europepmc   +1 more source